NO20050352L - Medikament for forhindring og/eller behandling av konstipasjon og symptomer pa konstipasjon - Google Patents

Medikament for forhindring og/eller behandling av konstipasjon og symptomer pa konstipasjon

Info

Publication number
NO20050352L
NO20050352L NO20050352A NO20050352A NO20050352L NO 20050352 L NO20050352 L NO 20050352L NO 20050352 A NO20050352 A NO 20050352A NO 20050352 A NO20050352 A NO 20050352A NO 20050352 L NO20050352 L NO 20050352L
Authority
NO
Norway
Prior art keywords
constipation
medication
treatment
symptoms
prevention
Prior art date
Application number
NO20050352A
Other languages
English (en)
Inventor
Hideo Kato
Osamu Nagata
Hiroyuki Nakano
Yasushi Okamoto
Ippei Tanaka
Tadasho Inoue
Tsutomu Inoue
Jun-Ichiro Uda
Original Assignee
Fuji Yakuhin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Yakuhin Co Ltd filed Critical Fuji Yakuhin Co Ltd
Publication of NO20050352L publication Critical patent/NO20050352L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Legemiddel for prevensjon og/eller behandling av konstipasjon og/eller symptomer forårsaket av konstipasjon, omfattende magnesiumpolykarbofil som en aktiv ingrediens. Dette legemiddel muliggjør regulær avføring uten bivirkninger som vandig diaré, for løs avføring og hyperkalsemi, og har derved god virkning.
NO20050352A 2002-06-26 2005-01-21 Medikament for forhindring og/eller behandling av konstipasjon og symptomer pa konstipasjon NO20050352L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002185790 2002-06-26
JP2003010905 2003-01-20
PCT/JP2003/008124 WO2004002499A1 (ja) 2002-06-26 2003-06-26 便秘及び便秘に伴う症状の予防及び／又は治療のための医薬

Publications (1)

Publication Number Publication Date
NO20050352L true NO20050352L (no) 2005-01-21

Family

ID=30002286

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050352A NO20050352L (no) 2002-06-26 2005-01-21 Medikament for forhindring og/eller behandling av konstipasjon og symptomer pa konstipasjon

Country Status (14)

Country Link
US (1) US20060051314A1 (no)
EP (1) EP1516623A1 (no)
JP (1) JP3662016B2 (no)
KR (1) KR20050046657A (no)
CN (1) CN1662247A (no)
AR (1) AR039750A1 (no)
AU (1) AU2003243986A1 (no)
BR (1) BR0312167A (no)
CA (1) CA2488039A1 (no)
MX (1) MXPA04012926A (no)
NO (1) NO20050352L (no)
RU (1) RU2005101768A (no)
TW (1) TW200404557A (no)
WO (1) WO2004002499A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101057861B (zh) * 2007-06-08 2010-07-28 广州朗圣药业有限公司 一种聚卡波菲肠溶药物组合物
CN105131159B (zh) * 2015-08-21 2017-05-31 浙江拓普药业股份有限公司 一种聚卡波非钙生产工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202577A (en) * 1962-05-25 1965-08-24 White Lab Inc Process of treating diarrhea with resins
NL129666C (no) * 1962-08-06
DE3776116D1 (de) * 1986-12-30 1992-02-27 American Cyanamid Co Zusammensetzung die ein polycarbophil enthaelt.
JP2609022B2 (ja) * 1990-11-29 1997-05-14 北陸製薬株式会社 ポリカルボフィルカルシウム含有製剤
JPH08502073A (ja) * 1992-09-30 1996-03-05 アセント ファーマシューティカルズ インコーポレイテッド カルシウムポリカルボフィルスプリンクル

Also Published As

Publication number Publication date
TW200404557A (en) 2004-04-01
US20060051314A1 (en) 2006-03-09
CA2488039A1 (en) 2004-01-08
KR20050046657A (ko) 2005-05-18
AU2003243986A1 (en) 2004-01-19
JP3662016B2 (ja) 2005-06-22
WO2004002499A1 (ja) 2004-01-08
EP1516623A1 (en) 2005-03-23
MXPA04012926A (es) 2005-05-16
JPWO2004002499A1 (ja) 2005-10-27
CN1662247A (zh) 2005-08-31
AR039750A1 (es) 2005-03-09
RU2005101768A (ru) 2005-06-27
BR0312167A (pt) 2005-03-29

Similar Documents

Publication Publication Date Title
HN2005000255A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
WO2005082414A3 (en) Concomitant drugs of a sulfonamide and another therapeutic agent
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
EP2322219A3 (en) Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease
NO20072542L (no) Pyrimidinderivat kondensert med ikke-aromatisk ring
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
BRPI0517088A (pt) formulação de comprimido estável
NO20076675L (no) Aminopiperidinquinoliner og deres azaisosteriske analoger med antibakteriell aktivitet
NZ720906A (en) Orally disintegrating solid dosage unit containing an estetrol component
NO20090797L (no) Farmasoytiske blandinger omfattende kandesartan cileksetil
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
NO20084276L (no) Orodispergerbare domperidontabletter
NO20080248L (no) Tablett inneholdende lite opploselig, aktiv bestanddel
DK1296972T3 (da) Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer
WO2005007137A3 (de) Ambroxolhaltige tabletten
WO2006076015A3 (en) 1-[2-(phosphonomethoxy)ethyl]-cytosine and analogs thereof
NO20050352L (no) Medikament for forhindring og/eller behandling av konstipasjon og symptomer pa konstipasjon
WO2005051350A3 (en) Water dispersible tablet
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
DZ3459A1 (fr) Derives de 2h-1-benzopyran, procedes de preparation de ces derniers et compositions pharmaceutiques dans lesquels ils entrent.
WO2009139504A3 (en) A solid pharmaceutical formulation
TW200640446A (en) Prophylactic anti-stress agent
NO20054157L (no) Formuleringer av venlafaksin med forsinket frigjoring
NO20044091L (no) Anvendelse av substituerte 3-fenyl-5-alkoksy-1,3,4-oksdiazol-2-on for fremstilling av medikamenter som inhiberer pankreatisk lipase
IS8202A (is) Deramsíklan-fúmarattöflur

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application